Anticipated shortage
Novartis/Amgen global supply renegotiation impacting Australian market allocation for anti-CGRP migraine preventatives.
Expected resolution: 31 October 2025
Alternatives:
- Discuss alternative migraine prevention with neurologist
- Topiramate (Topamax) — oral migraine prevention option
erenumab
Aimovig
70 mg/mL · injection · Migraine Prevention
PBS Pricing
| General patient co-payment | $31.60 |
| Concession co-payment | $7.70 |
| Full dispensed price | $484.80 |
PBS Information
- Item code
- NEUx10
- Drug name
- erenumab
- Brand name
- Aimovig
- Manufacturer
- Novartis
- Formulation
- injection
- Strength
- 70 mg/mL
- Max quantity
- 1 units
- Max repeats
- 5
- PBS listed
- Yes
- Therapeutic group
- Migraine Prevention
TGA Reference: TGA-MSI-2025-039 · Sponsor: Novartis Pharmaceuticals Australia Pty Ltd
MedWatch is for informational purposes only and does not constitute medical advice. Never stop or change your medicines without consulting your doctor or pharmacist. In an emergency, call 000. Medication queries: National Medicines Line 1300 633 424.